Phase I study of MP-201 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2017
At a glance
- Drugs MP-201 (Primary)
- Indications Diabetes mellitus; Neurodegenerative disorders; Neuromuscular disorders; Non-alcoholic steatohepatitis; Obesity
- Focus Adverse reactions
- 05 Oct 2017 New trial record
- 03 Oct 2017 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2018.